Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial.

Autor: Januzzi, James L.1,2,3 (AUTHOR) jjanuzzi@partners.org, Zannad, Faiez4 (AUTHOR), Anker, Stefan D.5 (AUTHOR), Butler, Javed6 (AUTHOR), Filippatos, Gerasimos7 (AUTHOR), Pocock, Stuart J.8 (AUTHOR), Ferreira, João Pedro9 (AUTHOR), Sattar, Naveed10 (AUTHOR), Verma, Subodh11 (AUTHOR), Vedin, Ola12 (AUTHOR), Schnee, Janet13 (AUTHOR), Iwata, Tomoko14 (AUTHOR), Cotton, Dan13 (AUTHOR), Packer, Milton15,16 (AUTHOR), Januzzi, James L Jr17 (AUTHOR), EMPEROR-Reduced Trial Committees and Investigators (CORPORATE AUTHOR)
Zdroj: Journal of the American College of Cardiology (JACC). Sep2021, Vol. 78 Issue 13, p1321-1332. 12p.
Databáze: Academic Search Ultimate